{"id":142467,"date":"2023-02-22T04:21:09","date_gmt":"2023-02-22T09:21:09","guid":{"rendered":"https:\/\/44.250.171.167\/?p=142467"},"modified":"2023-02-22T04:21:10","modified_gmt":"2023-02-22T09:21:10","slug":"earnings-summary-of-glaxosmithkline-pharmaceuticals-limited-for-q3-fy23","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/earnings-summary-of-glaxosmithkline-pharmaceuticals-limited-for-q3-fy23\/","title":{"rendered":"Earnings Summary Of GlaxoSmithKline Pharmaceuticals Limited For Q3 FY23"},"content":{"rendered":"

GlaxoSmithKline Pharmaceuticals Limited (NSE: GLAXO) is a leading pharmaceutical company in India that develops, manufactures, and markets a range of pharmaceutical products for various therapeutic areas. The company has a strong presence in India and a significant global footprint, with operations in more than 150 countries.<\/p>\n

In terms of earnings, Revenue from Operations for Q3 FY23 was \u20b9802.3 crore, a 1.7% decrease from \u20b9815.92 crore in the same period last year. The Other Income, generated a total of \u20b923.42 Crore to Total Revenue which jumped by 127% from the previous year same quarter.<\/p>\n

A total of \u20b9153 Crore were contributed by the Employee Benefit Expense to the Total Expense, an increased of 7.4% from the same quarter last year. The Consolidated Net Profit was \u20b9164.56 crore, up 9.4% from \u20b9150.35 crore in the same quarter last year. This quarter\u2019s earnings per share was \u20b99.71.<\/p>\n\n\n

<\/div>\n\n\n\n
\"\"<\/figure>\n","protected":false},"excerpt":{"rendered":"

GlaxoSmithKline Pharmaceuticals Limited (NSE: GLAXO) is a leading pharmaceutical company in India that develops, manufactures, and markets a range of pharmaceutical products for various therapeutic areas. The company has a strong presence in India and a significant global footprint, with operations in more than 150 countries. In terms of earnings, Revenue from Operations for Q3 […]<\/p>\n","protected":false},"author":1917,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392],"tags":[1115],"class_list":["post-142467","post","type-post","status-publish","format-standard","hentry","category-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":146522,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-glaxosmithkline-pharmaceuticals-limited-for-q4-fy23\/","url_meta":{"origin":142467,"position":0},"title":"Earnings Summary Of Glaxosmithkline Pharmaceuticals Limited For Q4 FY23","author":"Hardik Bhandare","date":"May 17, 2023","format":false,"excerpt":"GlaxoSmithKline Pharmaceuticals Limited is a renowned Indian pharmaceutical company that operates in the research, development, manufacturing, and marketing of a wide range of prescription medicines, vaccines, and consumer healthcare products. As a subsidiary of the global healthcare giant Glaxosmithkline, the company carries forward its legacy of innovation, quality, and commitment\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":142547,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-fdc-limited-for-q3-fy23\/","url_meta":{"origin":142467,"position":1},"title":"Earnings Summary Of FDC Limited For Q3 FY23","author":"Hardik Bhandare","date":"February 22, 2023","format":false,"excerpt":"FDC Limited (NSE: FDC) is a leading Indian pharmaceutical company that specializes in the manufacturing and marketing of a wide range of prescription and OTC drugs. The company has a strong presence in India and exports its products to more than 50 countries. FDC Limited has a diversified product portfolio\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-15.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-15.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-15.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-15.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-15.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-15.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":143124,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-lupin-limited-for-q3-fy23\/","url_meta":{"origin":142467,"position":2},"title":"Earnings Summary Of Lupin Limited For Q3 FY23","author":"Hardik Bhandare","date":"March 1, 2023","format":false,"excerpt":"Lupin Limited is a pharmaceutical company headquartered in Mumbai, India. The company was founded in 1968 and has operations in over 100 countries. Lupin is primarily engaged in the development, manufacture, and marketing of generic and branded pharmaceuticals, biosimilars, and specialty pharmaceuticals. The company has a diversified portfolio of products\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":142188,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-hikal-limited-for-q3-fy23\/","url_meta":{"origin":142467,"position":3},"title":"Earnings Summary Of Hikal Limited For Q3 FY23","author":"Hardik Bhandare","date":"February 17, 2023","format":false,"excerpt":"Hikal Limited (NSE: HIKAL) is a leading Indian life sciences company with a global presence. The company specializes in developing and manufacturing intermediates, active pharmaceutical ingredients (APIs), and specialty chemicals for the pharmaceutical, agrochemical, and animal health industries. HIKAL has a strong focus on innovation and quality, which has helped\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-1-3.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-1-3.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-1-3.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-1-3.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-1-3.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-1-3.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169742,"url":"https:\/\/alphastreet.com\/india\/glaxosmithkline-pharmaceuticals-ltd-q1-fy26-earnings-results-revenue-down-1-net-profit-rises-13-yoy\/","url_meta":{"origin":142467,"position":4},"title":"GlaxoSmithKline Pharmaceuticals Ltd Q1 FY26 Earnings Results \u2013 Revenue Down 1%, Net Profit Rises 13% YoY","author":"Divyansh_Kasana","date":"August 4, 2025","format":false,"excerpt":"GlaxoSmithKline Pharmaceuticals Limited (GSK Pharma) is a leading pharmaceutical company focused on researching, manufacturing, and making available a broad range of medicines and vaccines that benefit people in India and globally. The company consistently delivers innovation and quality across its therapeutic portfolio. (Source: Company Website) Q1 FY26 Earnings Summary (Apr\u2013Jun\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/GLA.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/GLA.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/GLA.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/GLA.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/GLA.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/GLA.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":142932,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-ipca-laboratories-limited-for-q3-fy23\/","url_meta":{"origin":142467,"position":5},"title":"Earnings Summary Of IPCA Laboratories Limited For Q3 FY23","author":"Hardik Bhandare","date":"February 27, 2023","format":false,"excerpt":"Ipca Laboratories (NSE: IPCALAB) is a leading pharmaceutical company in India that produces and markets a broad range of prescription and non-prescription drugs, APIs (Active Pharmaceutical Ingredients), and intermediates. The company was founded in 1949 and is headquartered in Mumbai, India. It has a global presence with operations in over\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/142467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1917"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=142467"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/142467\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=142467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=142467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=142467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}